Combined Effects of Intermittent Hypoxia and Amyloid Beta on Hippocampal Activity, Its Cholinergic Modulation, and
Pinedo-Vargas Laura1, Méndez-Salcido Felipe1, Lorea-Hernández Jonathan-Julio1
1Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
None:
Obstructive sleep apnea (OSA), characterized by repetitive upper airway obstruction, leads to chronic intermittent hypoxia (cIH) and induces cognitive and neuronal network disruptions similar to those observed in Alzheimer's disease (AD). These pathologies are often presented together in the elderly and share some pathophysiological mechanisms. The presence of amyloid beta (Aβ), observed both in AD and OSA patients, can alter brain function, cholinergic modulation and memory either independently or in addition with cIH. To explore these possibilities, we studied the pathological effects of Aβ, cIH, and their combination on cognition and hippocampal activity, and its modulations by the cholinomimetics carbachol, muscarine, and nicotine, along with evaluations of choline acetyltransferase (ChAT) expression in the septum and the hippocampus. We found that cIH and Aβ similarly affect spatial memory and additively impact aversive memory (sparing recognition memory). Although cIH and Aβ share some pathological effects on hippocampal activity and its modulation by cholinomimetics, when combined, they produce an additive inhibition at the population and single-cell levels more evident in the presence of nicotine. No change in ChAT expression was observed. Remarkably, the departure from normal firing as well as the disruption of carbachol-induced response correlates with the reduction of aversive memory in our experimental groups. In summary, cIH and Aβ share pathological effects, but their combination exacerbates functional pathology, contributing to our understanding of AD/OSA pathophysiology and co-morbidity.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Role of Hippocampus in Memory
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
